|
A Prospective Study of Alzheimer Disease in Down Syndrome
|
journal
|
August 1989 |
|
Donanemab in Early Symptomatic Alzheimer Disease
|
journal
|
August 2023 |
|
Correlation of Specific Amyloid-β Oligomers With Tau in Cerebrospinal Fluid From Cognitively Normal Older Adults
|
journal
|
May 2013 |
|
The biogenesis and biology of amyloid β oligomers in the brain
|
journal
|
June 2020 |
|
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
|
journal
|
November 2020 |
|
A Hexameric Peptide Barrel as Building Block of Amyloid-β Protofibrils
|
journal
|
September 2014 |
|
A Palette of Fluorescent Thiophene‐Based Ligands for the Identification of Protein Aggregates
|
journal
|
September 2015 |
|
Dementia in people with Down's syndrome
|
journal
|
December 2001 |
|
Neuropathology of Alzheimer's Disease
|
journal
|
January 2010 |
|
Peptide Compositions of the Cerebrovascular and Senile Plaque Core Amyloid Deposits of Alzheimer′s Disease
|
journal
|
February 1993 |
|
Diffuse type of senile plaques in the brains of Alzheimer-type dementia
|
journal
|
March 1988 |
|
Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease
|
journal
|
January 1989 |
|
Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer’s disease brain
|
journal
|
April 2018 |
|
The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer’s disease
|
journal
|
September 2020 |
|
The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome
|
journal
|
February 1989 |
|
Cerebral amyloid angiopathy and alzheimer's disease: two entities or one?
|
journal
|
October 1992 |
|
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
|
journal
|
July 1991 |
|
βA4 deposits are constant in the brain of the oldest old: An immunocytochemical study of 20 french centenarians
|
journal
|
March 1993 |
|
Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals
|
journal
|
November 1988 |
|
Appearance of Sodium Dodecyl Sulfate-Stable Amyloid β-Protein (Aβ) Dimer in the Cortex During Aging
|
journal
|
January 1999 |
|
Monoclonal antibodies as structural probes of surface residues in the regulatory subunit of cAMP-dependent protein kinase II from porcine heart.
|
journal
|
January 1983 |
|
Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy
|
journal
|
December 1990 |
|
Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease
|
journal
|
March 2002 |
|
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
|
journal
|
January 2010 |
|
Solid-state NMR analysis of the β-strand orientation of the protofibrils of amyloid β-protein
|
journal
|
November 2012 |
|
Exploring amyloid oligomers with peptide model systems
|
journal
|
October 2021 |
|
Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue
|
journal
|
September 2013 |
|
Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration
|
journal
|
June 2015 |
|
High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease
|
journal
|
November 2010 |
|
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|
journal
|
May 2011 |
|
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
|
journal
|
July 2017 |
|
Human cerebral vascular amyloid contains both antiparallel and parallel in-register Aβ40 fibrils
|
journal
|
November 2021 |
|
Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity
|
journal
|
August 2012 |
|
The Alzheimer's Amyloid-β(1–42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization
|
journal
|
July 2013 |
|
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
|
journal
|
December 2009 |
|
A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
|
journal
|
December 2012 |
|
Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer’s Disease and Other Amyloid Diseases
|
journal
|
March 2018 |
|
Nascent Hairpins in Proteins: Identifying Turn Loci and Quantitating Turn Contributions to Hairpin Stability
|
journal
|
September 2016 |
|
Experimental Constraints on Quaternary Structure in Alzheimer's β-Amyloid Fibrils †
|
journal
|
January 2006 |
|
Structural Characterization of a Soluble Amyloid β-Peptide Oligomer
|
journal
|
March 2009 |
|
Monoclonal Antibody Against the Turn of the 42-Residue Amyloid β-Protein at Positions 22 and 23
|
journal
|
September 2010 |
|
Minimization and Optimization of Designed β-Hairpin Folds
|
journal
|
April 2006 |
|
X-ray Crystallographic Structures of Trimers and Higher-Order Oligomeric Assemblies of a Peptide Derived from Aβ 17–36
|
journal
|
April 2014 |
|
Phenylalanine Mutation to Cyclohexylalanine Facilitates Triangular Trimer Formation by β-Hairpins Derived from Aβ
|
journal
|
November 2020 |
|
X-ray Crystallographic Structures of a Trimer, Dodecamer, and Annular Pore Formed by an Aβ17–36 β-Hairpin
|
journal
|
March 2016 |
|
Atomic Resolution Structure of Monomorphic Aβ 42 Amyloid Fibrils
|
journal
|
July 2016 |
|
Stabilization, Assembly, and Toxicity of Trimers Derived from Aβ
|
journal
|
January 2017 |
|
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
|
journal
|
April 2002 |
|
Post-hoc analysis could give new life to the Alzheimer’s drug aducanumab
|
journal
|
November 2020 |
|
A specific amyloid-β protein assembly in the brain impairs memory
|
journal
|
March 2006 |
|
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
|
journal
|
August 2016 |
|
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes
|
journal
|
January 2017 |
|
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
|
journal
|
June 2008 |
|
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
|
journal
|
January 2012 |
|
Alzheimer's disease
|
journal
|
October 2015 |
|
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
|
journal
|
February 2007 |
|
De novo design and structural analysis of a model β-hairpin peptide system
|
journal
|
July 1996 |
|
Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease
|
journal
|
May 2015 |
|
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
|
journal
|
July 2018 |
|
Aβ(1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage
|
journal
|
June 2020 |
|
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
|
journal
|
April 2018 |
|
Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis
|
journal
|
July 2016 |
|
Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies
|
journal
|
July 2014 |
|
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|
journal
|
August 2012 |
|
Alzheimer's Disease
|
journal
|
January 2010 |
|
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
|
journal
|
February 2005 |
|
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
|
journal
|
March 2008 |
|
Molecular structural basis for polymorphism in Alzheimer's -amyloid fibrils
|
journal
|
November 2008 |
|
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
|
journal
|
March 2009 |
|
Stabilization of neurotoxic Alzheimer amyloid- oligomers by protein engineering
|
journal
|
August 2010 |
|
Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
|
journal
|
March 2011 |
|
Antiparallel -sheet architecture in Iowa-mutant -amyloid fibrils
|
journal
|
March 2012 |
|
Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril
|
journal
|
July 2016 |
|
Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments
|
journal
|
September 2016 |
|
Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue
|
journal
|
January 2021 |
|
Probing differences among Aβ oligomers with two triangular trimers derived from Aβ
|
journal
|
May 2023 |
|
Diffusible, nonfibrillar ligands derived from A 1-42 are potent central nervous system neurotoxins
|
journal
|
May 1998 |
|
Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains
|
journal
|
November 2009 |
|
Two Distinct Amyloid β-Protein (Aβ) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses
|
journal
|
April 2011 |
|
Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain
|
journal
|
June 2011 |
|
Solid-state NMR Reveals a Close Structural Relationship between Amyloid-β Protofibrils and Oligomers
|
journal
|
June 2012 |
|
Monoclonal Antibodies as Structural Probes for Oligomeric Human Interferon-Gamma
|
journal
|
January 1985 |
|
Brain amyloid-β oligomers in ageing and Alzheimer’s disease
|
journal
|
April 2013 |
|
Rapidly progressive Alzheimer’s disease features distinct structures of amyloid-β
|
journal
|
February 2015 |
|
Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer’s brain
|
journal
|
April 2019 |
|
Amyloid beta oligomers induce impairment of neuronal insulin receptors
|
journal
|
August 2007 |
|
The Pathogenesis of Senile Plaques
|
journal
|
April 1997 |
|
Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains
|
journal
|
February 2018 |
|
Early Senile Plaques in Down'S Syndrome Brains show a Close Relationship with cell Bodies of Neurons
|
journal
|
December 1989 |
|
Monoclonal antibodies that target pathological assemblies of Aβ
|
journal
|
August 2006 |
|
Sensitive ELISA detection of amyloid‐β protofibrils in biological samples
|
journal
|
June 2007 |
|
The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region
|
journal
|
November 2017 |
|
Review: Vascular dementia: clinicopathologic and genetic considerations
|
journal
|
March 2018 |
|
Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers
|
journal
|
April 2006 |
|
Alzheimer's Disease Is a Synaptic Failure
|
journal
|
October 2002 |
|
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
|
journal
|
April 2003 |
|
Fibril structure of amyloid-β(1–42) by cryo–electron microscopy
|
journal
|
September 2017 |
|
Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes
|
journal
|
July 2019 |
|
Treatments for Alzheimer's disease emerge
|
journal
|
August 2021 |
|
Alzheimer’s drugs: Does reducing amyloid work?—Response
|
journal
|
October 2021 |
|
Cryo-EM structures of amyloid-β 42 filaments from human brains
|
journal
|
January 2022 |
|
Blots on a field?
|
journal
|
July 2022 |
|
Alzheimer’s target still viable but untested
|
journal
|
August 2022 |
|
The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation
|
journal
|
May 2017 |
|
Beta-Amyloid Deposition in the Medial Temporal Lobe in Elderly Non-Demented Brains and in Alzheimer’s Disease
|
journal
|
January 1995 |
|
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
|
journal
|
January 2007 |
|
Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers
|
journal
|
January 2010 |
|
The neuropathological diagnosis of Alzheimer’s disease
|
journal
|
August 2019 |
|
Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
|
journal
|
April 2016 |
|
Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
|
journal
|
August 2020 |
|
Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
|
journal
|
December 2022 |
|
Late-onset Alzheimer Disease
|
journal
|
February 2019 |
|
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
|
journal
|
August 2019 |
|
Risk Factors for Dementia in People With Down Syndrome: Issues in Assessment and Diagnosis
|
journal
|
January 2004 |
|
Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation
|
journal
|
October 2006 |
|
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
|
journal
|
November 2016 |
|
Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport
|
journal
|
September 2016 |
|
Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP
|
journal
|
November 2017 |
|
Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
|
journal
|
October 2010 |
|
The amyloid hypothesis of Alzheimer's disease at 25 years
|
journal
|
March 2016 |
|
Aβ plaques
|
text
|
January 2020 |
|
Microvasculature in Brain Biopsy Specimens from Patients with Alzheimer's Disease: An Immunohistochemical and Ultrastructural Study
|
journal
|
January 1994 |
|
The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
|
journal
|
November 2014 |
|
Non-Fibrillar Oligomeric Amyloid-β within Synapses
|
journal
|
August 2016 |
|
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
|
journal
|
June 2018 |
|
Alzheimer's Disease and the Amyloid-β Peptide
|
journal
|
January 2010 |
|
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
|
journal
|
April 2022 |
|
Massive antibody discovery used to probe structure–function relationships of the essential outer membrane protein LptD
|
journal
|
June 2019 |